Abbott has agreed to a $385 million settlement over the closure of the largest baby formula plant in the U.S., which led to the supply shortages in 2022.
Abbott Laboratories says that it will pay $385 million to resolve claims tied to an investigation and lawsuit brought by the Justice Department related to its manufacturing and 2022 recall of powdered infant formula at a Michigan facility
<iframe src="https://statesidedaily.com/embed/cluster/4843429533ffcfd840e9c370dc2ccf7cd92782ee" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Abbott agrees to settlement over closure of largest baby formula plant in the U.S."></iframe>
Abbott has agreed to a $385 million settlement over the closure of the largest baby formula plant in the U.S., which led to the supply shortages in 2022.
